Meningococcal Disease Completed Phase 3 Trials for Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)

IndicationStatusPhase
DBCOND0033309 (Meningococcal Disease)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01466387A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsPrevention